Global Cell Counting Market

Posted by NISHA SHAHA on February 11th, 2022

The global cell counting market accounted for US$ 11.1 billion in 2020 and is estimated to be US$ 19.7 billion by 2029 and is anticipated to register a CAGR of 6.6%.

The report \" Global Cell Counting Market, By  Product (Instruments and Consumables & Accessories), By End-user (Research & Academic Institutes, Hospitals & Diagnostic Labs, Biotechnology & Pharmaceutical Companies, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029”.

Key Highlights:

• In 2019, DeNovix Inc. is pleased to announce that the winner of their recent competition to receive a donation of a unique, pink Cell Drop Automated Cell Counter is Beth Kahkonen, from the University of Pittsburgh, USA. Selected at random from thousands of entries from scientists worldwide, the CellDrop will be housed in the University’s Division of Pulmonary, Allergy, and Critical Care Medicine.
• HORIBA UK Ltd, Medical has introduced a new automated digital cell morphology solution in collaboration with CellaVision to help hematology laboratories.

Analyst View:

Increasing developments in cell counting instruments

Global cell counting market primarily attributed to the major drivers in this market such as the increased need for non-invasive diagnosis, advancements in single cell sequencing technique, and increase in adoption of personalized medicine. These individualized care regimes are improving quality of life of the patients and reducing economic, societal, and clinical burden, projecting a future of prosperity.

Key Market Insights from the report:        

The global cell counting market accounted for US$ 11.1 billion in 2020 and is estimated to be US$ 19.7 billion by 2029 and is anticipated to register a CAGR of 6.6%. The market report has been segmented on the basis of product, application, and region.

• Based on the product the global market is segmented into instruments and consumables & accessories. The instruments segment is further sub segmented as spectrometers, flow cytometers, hematology analyzers and cell counters. Similarly, the consumables & accessories is segmented as kits and reagents, accessories and others. Spectrophotometers are predicted to hold the largest market share due to its capability to measure different intensities of light accuracy and its applications in bioprocessing, therapeutics, and research.
• Based on the application, the market is bifurcated into research institutes, hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies, and others. Hospitals & Diagnostic Laboratories are anticipated to have the highest CAGR in the forecast period. The factors can be attributed to the rising pharmaceutical R&D expenditure and increasing regulatory approvals for cell culture-based vaccines.
• By region, North America is anticipated to dominate the cell counting market followed by Europe in the global scenario leads to various technological developments in the healthcare industry and rising research activities in the cytology with more funds available by the government. Asia Pacific market is expected to witness significant growth rate during the forecast period owing to the opportunities in the emerging economies and increasing R&D expenditures for the healthcare sectors.

To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Global-Cell-Counting-Market-4522